Nathalie H. E. Bossuyt - Infectious Diseases

Author Information

Nathalie H. E. Bossuyt is a researcher affiliated with the Epidemiology of Infectious Diseases department at Sciensano, located in Brussels, Belgium. Her work primarily focuses on infectious diseases, with significant contributions to studies on influenza, COVID-19, and other respiratory viruses.

Research Contributions

Nathalie Bossuyt has made substantial contributions to the field of infectious diseases, with a particular emphasis on surveillance and analysis of respiratory viruses. Her research includes evaluating the protective effects of antiviral treatments, extending influenza surveillance to non-influenza viruses, and establishing national surveillance systems for COVID-19 hospitalizations. She has also explored host genetic factors that influence influenza severity and the role of viral genomic information in predicting infection severity. Her work is crucial in informing public health strategies and improving disease prevention and control measures.

Aliases

Nathalie H. E. Bossuyt is also known by several aliases, including N Bossuyt, N. Bossuyt, and Nathalie Bossuyt. These variations may appear in different publications and citations.

Publication and Citation Metrics

Metric	Value
Citation Count	2083
h-index	23
Paper Count	82

Publications:

Protective Effect of Antiviral Treatment of Hospitalised Influenza Patients on the Risk of Death, EU 2010-2020

DOI: 10.2139/ssrn.4028556

Year: 2022

Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, 2015-2019, Belgium

DOI: 10.1101/2021.01.13.20202200

Year: 2021

Correction to: Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium

DOI: 10.1186/s13690-021-00661-w

Year: 2021

A systematic review and meta-analysis of host genetic factors associated with influenza severity

DOI: 10.1186/s12864-021-08240-7

Year: 2021

Prioritisation for future surveillance, prevention and control of 98 communicable diseases in Belgium: a 2018 multi-criteria decision analysis study

DOI: 10.1186/s12889-020-09566-9

Year: 2021

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study

DOI: 10.1016/S2666-5247(20)30221-4

Year: 2021

Spotlight influenza: Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, Belgium, 2015 to 2019

DOI: 10.2807/1560-7917.ES.2021.26.38.2001104

Year: 2021

Bronchiolitis in COVID-19 times: a nearly absent disease?

DOI: 10.1007/s00431-021-03968-6

Year: 2021

Evaluation of the added value of viral genomic information for predicting severity of influenza infection

DOI: 10.1186/s12879-021-06510-z

Year: 2021

All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century

DOI: 10.1186/s13690-020-00496-x

Year: 2020

What is the Future of the Global Fund?

What is Genomic Sequencing?

How Does the NIH Collaborate with Other Organizations?

What is Community Hygiene and its Importance?

What are Structural Proteins?

How Can Asymptomatic Infections Be Detected?

How is Avian Influenza Diagnosed?

What Measures Can Be Taken to Control the Spread?

How is West Nile Virus Diagnosed?

How Does Climate Change Affect Water-Borne Diseases?

Partnered Content Networks

Relevant Topics